A woman stands in a laboratory wearing a white coat and glasses and holds up a glass vial

UQ researchers have discovered a link between obstructive sleep apnoea and an increased risk of developing dementia.

9 November 2022

Inadequate oxygen levels during sleep can damage the brain and increase the risk of developing Alzheimer’s disease, University of Queensland researchers have found.

1 February 2018
A slice through a spinal column showing the physical connection that links the brain to muscles.

Motor neurone disease may still be considered a certain and unpleasant death sentence, but researchers at The University of Queensland are testing a promising treatment option.

25 February 2016
UQ scientists have found MRI’s could be used to predict Alzheimer’s disease.

Scientists at the University of Queensland have discovered that magnetic resonance imaging (MRI) could be used to predict the risk of Alzheimer’s disease.

13 January 2015

Scientists can now detect early features of Alzheimer’s disease using magnetic resonance imaging (MRI) scans.

11 February 2013

A Queensland Brain Institute neuroscientist at UQ is working on ways to reduce neuronal loss in the brain of a person with Alzheimer’s disease.

24 September 2008

The University of Queensland has paid tribute to its emerging research leaders, awarding more than $800,000 at the annual UQ Foundation Research Excellence Awards.

23 September 2008

Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease.

10 June 2008

UQ’s newest brain disorder research lab was opened this afternoon in honour of the self-made millionaire Peter Goodenough who lost his life to motor neuron disease (MND).

19 March 2008

Queensland Brain Institute (QBI) scientists have found another important clue to why nerve cells die in neurodegenerative diseases, based on studies of the developing brain.

6 February 2008

UniQuest Pty Limited is working with three University of Queensland scientists to commercialise a unique contrast agent to enhance the use of MRI in treating cancer and brain diseases.

29 August 2005